(Q48230329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ahmet Hacimuftuoglu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Mustafa Gulec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Elif Oral

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Onur B Dursun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Atakan Yucel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Fatih Akcay

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

21 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

Psychiatry and Clinical Neurosciences

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

50-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23279761%20AND%20SRC:MED&resulttype=core&format=json

The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Platinum neurotoxicity pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Neurotoxicity caused by the treatment with platinum analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Drosophila melanogaster: a new model to study cisplatin-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Developing central nervous system and vulnerability to platinum compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

L-carnitine inhibits hypoglycemia-induced brain damage in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Protective effects of acetyl-L-carnitine on cisplatin cytotoxicity and oxidative stress in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Comparative effects of α lipoic acid and melatonin on cisplatin-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: a 52-week follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Protective effect of mirtazapine on indomethacin-induced ulcer in rats and its relationship with oxidant and antioxidant parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Adaptation of rat gastric tissue against indomethacin toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Neurologic toxicities of cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Role of MAPKs in platinum-induced neuronal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

The effects of stress and aging on glutathione metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

The ameliorative effect of 23-hydroxytormentic acid isolated from Rubus coreanus on cisplatin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Effect of fructose-1,6-bisphosphate on the nephrotoxicity induced by cisplatin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Signal molecules and receptors in the differential development of cerebellum lobules. Acute effects of cisplatin on nitric oxide and glutamate systems in Purkinje cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Altered regulation of nitric oxide and natriuretic peptide system in cisplatin-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Exploring the potential of flunarizine for Cisplatin-induced painful uremic neuropathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Ameliorative influence of Urtica dioica L against cisplatin-induced toxicity in mice bearing Ehrlich ascites carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Detection of a mouse OGG1 fragment during caspase-dependent apoptosis: oxidative DNA damage and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Platinum complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Caspase substrates and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Platinum complex toxicity in cultured renal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Central and peripheral nervous system toxicity of common chemotherapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Involvement of 5-hydroxytryptaminergic transmission for the Mesobuthus tamulus venom-induced depression of spinal reflexes in neonatal rat in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X

Phase II trial of mirtazapine for cancer-related cachexia and anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2012.02395.X